These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 26133637)

  • 1. Comment on "ROC analysis in patient specific quality assurance" [Med. Phys. 40(4), 042103 (7pp.) (2013)].
    Smith WP; Phillips MH
    Med Phys; 2015 Jul; 42(7):4411-2. PubMed ID: 26133637
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to "Comment on 'ROC analysis in patient specific quality assurance' " [Med. Phys. 40, 042103 (7pp.) (2013)].
    Carlone M; MacPherson M; Cruje C; Rangel A; McCabe R; Nielsen M
    Med Phys; 2015 Jul; 42(7):4413. PubMed ID: 26133638
    [No Abstract]   [Full Text] [Related]  

  • 3. ROC analysis in patient specific quality assurance.
    Carlone M; Cruje C; Rangel A; McCabe R; Nielsen M; Macpherson M
    Med Phys; 2013 Apr; 40(4):042103. PubMed ID: 23556913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Point/Counterpoint. EPID dosimetry must soon become an essential component of IMRT quality assurance.
    van Elmpt W; Ezzell GA; Orton CG
    Med Phys; 2009 Oct; 36(10):4325-7. PubMed ID: 19928062
    [No Abstract]   [Full Text] [Related]  

  • 5. An automated procedure for the quality assurance of electron beam output and energy.
    Woo MK; Videla NG
    Med Phys; 2004 May; 31(5):972-4. PubMed ID: 15191280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-related quality assurance with different combinations of treatment planning systems, techniques, and machines : A multi-institutional survey.
    Steiniger B; Berger R; Eilzer S; Kornhuber C; Lorenz K; Peil T; Reiffenstuhl C; Schilz J; Schröder D; Schwedas M; Pensold S; Walke M; Weibert K; Wolf U; Wiezorek T
    Strahlenther Onkol; 2017 Jan; 193(1):46-54. PubMed ID: 27812732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comment on "In vivo diode dosimetry for routine quality assurance in IMRT".
    Jornet N
    Med Phys; 2004 Jun; 31(6):1642-3; author reply 1644. PubMed ID: 15259668
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of routine quality assurance procedures to detect the loss of a linear accelerator primary scattering foil.
    Davis MG; Nyerick CE; Horton JL; Hogstrom KR
    Med Phys; 1996 Apr; 23(4):521-2. PubMed ID: 9157264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and physical quality assurance for intensity modulated radiotherapy of prostate cancer.
    Boehmer D; Bohsung J; Eichwurzel I; Moys A; Budach V
    Radiother Oncol; 2004 Jun; 71(3):319-25. PubMed ID: 15172148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Risk analysis in radiotherapy].
    Francois P; Lartigau E
    Cancer Radiother; 2009 Oct; 13(6-7):574-80. PubMed ID: 19767227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a one-stop beam verification system using electronic portal imaging devices for routine quality assurance.
    Lim S; Ma SY; Jeung TS; Yi BY; Lee SH; Lee S; Cho SJ; Choi J
    Med Dosim; 2012; 37(3):296-304. PubMed ID: 22277157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EPID-based daily quality assurance of linear accelerators will likely replace other methods within the next ten years.
    Mutic S; Pawlicki T; Orton CG
    Med Phys; 2016 Jun; 43(6):2691-2693. PubMed ID: 27277015
    [No Abstract]   [Full Text] [Related]  

  • 13. IMRT quality assurance using a second treatment planning system.
    Anjum MN; Parker W; Ruo R; Aldahlawi I; Afzal M
    Med Dosim; 2010; 35(4):274-9. PubMed ID: 19944590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-specific quality assurance method for VMAT treatment delivery.
    Schreibmann E; Dhabaan A; Elder E; Fox T
    Med Phys; 2009 Oct; 36(10):4530-5. PubMed ID: 19928084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial clinical experience with ArcCHECK for IMRT/VMAT QA.
    Aristophanous M; Suh Y; Chi PC; Whittlesey LJ; LaNeave S; Martel MK
    J Appl Clin Med Phys; 2016 Sep; 17(5):20-33. PubMed ID: 27685107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of monitor chamber calibration on virtual Wedge dosimetry.
    Malkoske KE; Nakonechny KD
    Med Phys; 2007 Apr; 34(4):1185-92. PubMed ID: 17500449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An overview of the comprehensive proton therapy machine quality assurance procedures implemented at The University of Texas M. D. Anderson Cancer Center Proton Therapy Center-Houston.
    Arjomandy B; Sahoo N; Zhu XR; Zullo JR; Wu RY; Zhu M; Ding X; Martin C; Ciangaru G; Gillin MT
    Med Phys; 2009 Jun; 36(6):2269-82. PubMed ID: 19610316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comment on "Dose homogeneity specification for reference dosimetry of nonstandard fields" [Med. Phys. 39, 407-414 (2012)].
    Thomas SJ; Tudor GS
    Med Phys; 2013 Mar; 40(3):037101. PubMed ID: 23464346
    [No Abstract]   [Full Text] [Related]  

  • 19. Reply to "Comment on 'Dose homogeneity specification for reference dosimetry of nonstandard fields'" [Med. Phys. 39, 407-414 (2012)].
    Seuntjens J; Chung E; Soisson E
    Med Phys; 2013 Mar; 40(3):037102. PubMed ID: 23464347
    [No Abstract]   [Full Text] [Related]  

  • 20. A statistical approach to IMRT patient-specific QA.
    Palaniswaamy G; Scott Brame R; Yaddanapudi S; Rangaraj D; Mutic S
    Med Phys; 2012 Dec; 39(12):7560-70. PubMed ID: 23231304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.